Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Oct;35(10):1375–1378. doi: 10.1136/gut.35.10.1375

Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.

M Suzuki 1, S Miura 1, M Mori 1, A Kai 1, H Suzuki 1, D Fukumura 1, M Suematsu 1, M Tsuchiya 1
PMCID: PMC1375008  PMID: 7959190

Abstract

The effect of rebamipide, a novel antiulcer compound, on Helicobacter pylori activated neutrophil dependent in vitro gastric epithelial cell injury was investigated. Luminol dependent chemiluminescence (ChL), which detects toxic oxidants from neutrophils exhibited a 12-fold increase when the bacterial suspension of H pylori was added to the isolated human neutrophils. This change was significantly attenuated by rebamipide at a concentration less than 1 mM, showing that rebamipide may inhibit oxidant production from H pylori elicited neutrophils. To assess whether rebamipide attenuates gastric mucosal injury, we tested its inhibitory action on H pylori induced gastric mucosal damage associated with neutrophils in vitro. Rabbit gastric mucosal cells were monolayered in culture wells and coincubated with human neutrophils and H pylori, and the cytotoxicity index was then calculated. Cultured gastric cells were significantly damaged when they were incubated with human neutrophils activated by H pylori. This cellular damage was attenuated by rebamipide in a dose-dependent manner. Furthermore, spectrophotometrical measurement showed that rebamipide (1 mM) inhibits urease activity by 21.7%. As monochloramine (an oxidant yielded by reaction of neutrophil derived chlorinated oxidant and ammonia) is proposed as an important toxic molecule in this model, the current findings suggest that the preventive effect of rebamipide on H pylori elicited neutrophil induced gastric mucosal injury may result from its inhibitory actions on the neutrophilic oxidative burst as well as H pylori derived urease activity.

Full text

PDF
1375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craig P. M., Territo M. C., Karnes W. E., Walsh J. H. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut. 1992 Aug;33(8):1020–1023. doi: 10.1136/gut.33.8.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ishihara K., Komuro Y., Nishiyama N., Yamasaki K., Hotta K. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung. 1992 Dec;42(12):1462–1466. [PubMed] [Google Scholar]
  3. Kozol R., Domanowski A., Jaszewski R., Czanko R., McCurdy B., Prasad M., Fromm B., Calzada R. Neutrophil chemotaxis in gastric mucosa. A signal-to-response comparison. Dig Dis Sci. 1991 Sep;36(9):1277–1280. doi: 10.1007/BF01307522. [DOI] [PubMed] [Google Scholar]
  4. Kozol R., McCurdy B., Czanko R. A neutrophil chemotactic factor present in H. pylori but absent in H. mustelae. Dig Dis Sci. 1993 Jan;38(1):137–141. doi: 10.1007/BF01296786. [DOI] [PubMed] [Google Scholar]
  5. Mai U. E., Perez-Perez G. I., Allen J. B., Wahl S. M., Blaser M. J., Smith P. D. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med. 1992 Feb 1;175(2):517–525. doi: 10.1084/jem.175.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  7. Mooney C., Keenan J., Munster D., Wilson I., Allardyce R., Bagshaw P., Chapman B., Chadwick V. Neutrophil activation by Helicobacter pylori. Gut. 1991 Aug;32(8):853–857. doi: 10.1136/gut.32.8.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol. 1987 Mar;82(3):192–199. [PubMed] [Google Scholar]
  9. Neithercut W. D., Milne A., Chittajallu R. S., el Nujumi A. M., McColl K. E. Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut. 1991 Sep;32(9):973–976. doi: 10.1136/gut.32.9.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ogino K., Hobara T., Ishiyama H., Yamasaki K., Kobayashi H., Izumi Y., Oka S. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol. 1992 Feb 25;212(1):9–13. doi: 10.1016/0014-2999(92)90065-c. [DOI] [PubMed] [Google Scholar]
  11. Oka S., Ogino K., Hobara T., Yoshimura S., Okazaki Y., Takemoto T., Iida Y. Effects of various mucosal protective drugs on diethyldithiocarbamate-induced antral ulcer in rats. Eur J Pharmacol. 1991 May 2;197(1):99–102. doi: 10.1016/0014-2999(91)90370-6. [DOI] [PubMed] [Google Scholar]
  12. Suematsu M., Oshio C., Miura S., Suzuki M., Houzawa S., Tsuchiya M. Luminol-dependent photoemission from single neutrophil stimulated by phorbol ester and calcium ionophore--role of degranulation and myeloperoxidase. Biochem Biophys Res Commun. 1988 Aug 30;155(1):106–111. doi: 10.1016/s0006-291x(88)81055-6. [DOI] [PubMed] [Google Scholar]
  13. Suzuki M., Miura S., Suematsu M., Fukumura D., Kurose I., Suzuki H., Kai A., Kudoh Y., Ohashi M., Tsuchiya M. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol. 1992 Nov;263(5 Pt 1):G719–G725. doi: 10.1152/ajpgi.1992.263.5.G719. [DOI] [PubMed] [Google Scholar]
  14. Tsujii M., Kawano S., Tsuji S., Fusamoto H., Kamada T., Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology. 1992 Jun;102(6):1881–1888. doi: 10.1016/0016-5085(92)90309-m. [DOI] [PubMed] [Google Scholar]
  15. Yamasaki K., Kanbe T., Chijiwa T., Ishiyama H., Morita S. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol. 1987 Oct 6;142(1):23–29. doi: 10.1016/0014-2999(87)90649-2. [DOI] [PubMed] [Google Scholar]
  16. Yoshida N., Granger D. N., Evans D. J., Jr, Evans D. G., Graham D. Y., Anderson D. C., Wolf R. E., Kvietys P. R. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology. 1993 Nov;105(5):1431–1440. doi: 10.1016/0016-5085(93)90148-6. [DOI] [PubMed] [Google Scholar]
  17. Yoshikawa T., Naito Y., Tanigawa T., Kondo M. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung. 1993 Mar;43(3):363–366. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES